Taibang Biologic Group’s $300 Million Equity Raising

Davis Polk advised Taibang Biologic Group on the transaction.Taibang Biologic Group (previously listed as China Biologic Products Holdings on the Nasdaq Global Select Market under the…

This content is for members only.
Login to Read More Join Now
Laura Testa

Author: Laura Testa

This content is for members only.
Login to Read More Join Now